Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 5, 2011, Pages 954-961

  Lin, Shih Wen ^a   Freedman, Neal D ^a   Hollenbeck, Albert R ^b   Schatzkin, Arthur ^a   Abnet, Christian C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AARP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CARDIA CARCINOMA; CASE CONTROL STUDY; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GASTRIC NONCARDIA ADENOCARCINOMA; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SELF REPORT; STOMACH ADENOCARCINOMA; UNITED STATES; UPPER GASTROINTESTINAL TRACT;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SELF REPORT;

EID: 79955768376     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1244     Document Type: Article

References (45)

1. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R. Diabetes and cancer. Endocr Relat Cancer 2009;16:1103-23.
2. Mitri J, Castillo J, Pittas AG. Diabetes and risk of Non-Hodgkin's lymphoma: a meta-analysis of observational studies. Diabetes Care 2008;31:2391-7.
3. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007;121:856-62. (Pubitemid 47106217)
4. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005;97:1679-87. (Pubitemid 41672234)
5. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007;50:1365-74. (Pubitemid 46879010)
6. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006;4:369-80. (Pubitemid 43343895)
7. Larsson SC, Andersson SO, Johansson JE, Wolk A. Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer 2008;44:2655-60.
8. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005;92:2076-83. (Pubitemid 40897433)
9. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2056-62. (Pubitemid 44877026)
10. Renehan A, Smith U, Kirkman MS. Linking diabetes and cancer: a consensus on complexity. Lancet 2010;375:2201-2.
11. Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer 2008;123:1422-8.
12. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
13. Devesa SS, Blot WJ, Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
14. Devesa SS, Fraumeni JF, Jr. The rising incidence of gastric cardia cancer. J Natl Cancer Inst 1999;91:747-9. (Pubitemid 29239054)
15. Corley DA, Kubo A. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst 2004;96:1383-7. (Pubitemid 39406172)
16. Anderson WF, Camargo MC, Fraumeni JF, Jr., Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 2010;303:1723-8.
17. Whiteman DC, Sadeghi S, Pandeya N, Smithers BM, Gotley DC, Bain CJ, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008;57:173-80. (Pubitemid 351158042)
18. Chow W-H, Fraumeni JF, Jr., Blot WJ, Vaughan TL, Stanford JL, Farrow DC, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998;90:150-5. (Pubitemid 28114417)
19. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollen-beck AR, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: The National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001;154:1119-25. (Pubitemid 33140635)
20. Rubenstein JH, Davis J, Marrero JA, Inadomi JM. Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia. Aliment Pharmacol Ther 2005;22:267-71. (Pubitemid 41153070)
21. Cheng KK, Sharp L, McKinney PA, Logan RF, Chilvers CE, Cook-Mozaffari P, et al. A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 2000;83:127-32. (Pubitemid 30352729)
22. Neale RE, Doecke JD, Pandeya N, Sadeghi S, Green AC, Webb PM, et al. Does type 2 diabetes influence the risk of oesophageal adenocarcinoma? Br J Cancer 2009;100:795-8.
23. Hemminki K, Li X, Sundquist J, Sundquist K. Risk of cancer following hospitalization for type 2 diabetes. Oncologist 2010;15:548-55.
24. Kuriki K, Hirose K, Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prevention 2007;16:83-9, doi:10.1097/01.cej.0000228404.37858.40. (Pubitemid 46105011)
25. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006;166:1871-7. (Pubitemid 44455170)
26. Yoshizawa N, Yamaguchi H, Yamamoto M, Shimizu N, Furihata C, Tatematsu M, et al. Gastric carcinogenesis by N-methyl-N-nitrosourea is enhanced in db/db diabetic mice. Cancer Science 2009;100:1180-5.
27. Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr Diabetes Rev 2006;2:195-211.
28. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007;117:60-9. (Pubitemid 46048450)
29. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and Type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-56.e5.
30. Herron DM, Tong W. Role of surgery in management of type 2 diabetes mellitus. Mt Sinai J Med 2009;76:281-93.
31. Sultan S, Gupta D, Parikh M, Youn H, Kurian M, Fielding G, et al. Fiveyear outcomes of patients with type 2 diabetes who underwent laparoscopic adjustable gastric banding. Surgery Obes Relat Dis 2010;6:373-6.
32. Herbella FA, Tineli AC, Wilson JL, Jr, Del Grande JC. Duodenal bypass does not decrease glucose levels of lean individuals with gastric cancer submitted to partial or total gastrectomy. Arquivos de Gastroenterologia 2009;46:230-2.
33. Lanzarini E, Csendes A, Lembach H, Molina J, Gutiérrez L, Silva J. Evolution of Type 2 diabetes mellitus in non morbid obese gastrectomized patients with Roux en-Y reconstruction: retrospective study. World J Surg 2010;34:2098-102.
34. Zervos EE, Agle SC, Warren AJ, Lang CG, Fitzgerald TL, Dar M, et al. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of Type II diabetes. J Am College Surgeons 2010;210:564-72.
35. Clements RH, Gonzalez QH, Long CI, Wittert G, Laws HL. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg 2004;70:1-4; discussion -5.
36. Saliba J, Wattacheril J, Abumrad NN. Endocrine and metabolic response to gastric bypass. Curr Opin Clin Nutr Metab Care 2009;12:515-21.
37. Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF, Jr, Leitzmann M, Schatzkin A. A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer 2008;44:465-71.
38. Whiteman DC, Parmar P, Fahey P, Moore SP, Stark M, Zhao ZZ, et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010;139:73-83.
39. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;98:1445-52. (Pubitemid 44605589)
40. Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004;96:388-96. (Pubitemid 38351300)
41. Tisnado DM, Adams JL, Liu H, Damberg CL, Chen WP, Hu FA, et al. What is the concordance between the medical record and patient selfreport as data sources for ambulatory care? Med Care 2006;44:132-40.
42. Skinner KM, Miller DR, Lincoln E, Lee A, Kazis LE. Concordance between respondent self-reports and medical records for chronic conditions: experience from the Veterans Health Study. J Ambul Care Manage 2005;28:102-10. (Pubitemid 40478361)
43. National Diabetes Statistics, 2007 fact sheet. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Department of Health and Human Services, National Institutes of Health; 2008.
44. Zendehdel K, Nyrén O, Östenson C-G, Adami H-O, Ekbom A, Ye W. Cancer incidence in patients with Type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Instit 2003;95:1797-800. (Pubitemid 38008903)
45. Acbay O, Celik AF, Gundogdu S. Does Helicobacter pylori-induced gastritis enhance food-stimulated insulin release? Dig Dis Sci 1996;41:1327-31.